Oversight is only as strong as the evidence behind it

Compliance
Compliance
Compliance
By Valentina Soares
The EU AI Act requires more than human involvement in high-risk AI systems. Article 14 requires those responsible for oversight to remain aware of the risk of over-reliance on AI output and to be capable of disregarding, overriding or reversing it when appropriate and proportionate.
For regulated organizations, that creates an important distinction. Evidence that a human reviewed or approved an AI-generated output is not necessarily evidence that meaningful human oversight occurred. A name, approval and timestamp can establish participation. They provide little insight into whether the reviewer independently evaluated the output, challenged a conclusion or identified an error.
Meaningful oversight therefore requires workflows that support independent human judgment and preserve credible evidence of the conditions and actions surrounding it. Oversight is only as strong as the evidence behind it.
A record of review is not evidence of meaningful review
Life sciences quality systems already distinguish between generating a record and operating an effective control. Annex 11 requires audit trails to be available, intelligible and regularly reviewed, while Part 11 requires secure, computer-generated, time-stamped audit trails of actions affecting electronic records.
These requirements do not establish a standard for evidencing human judgment over AI output, but they provide a useful precedent: the existence of a record does not demonstrate that the underlying control operated effectively.
An AI audit trail may establish who acted, what changed and when. It cannot establish whether a reviewer critically evaluated the substance of an AI-generated output. A workflow cannot record cognition, but it can support independent judgment and preserve relevant evidence of how the oversight process operated.
Reviewer expertise does not eliminate automation bias
Human-factors research demonstrates why a qualified reviewer is not sufficient on its own.
In a 2023 Radiology study, 27 radiologists evaluated mammograms accompanied by AI-suggested assessment categories, some deliberately incorrect. Readers at every level of experience were influenced by the incorrect recommendations. Greater experience reduced the effect but did not eliminate it.
Although reading a mammogram differs substantially from reviewing regulated documentation, the underlying mechanism is relevant: professional expertise does not eliminate susceptibility to incorrect AI recommendations.
Providing more information is not necessarily sufficient either. Operators using automated decision aids may fail to consult information capable of revealing an incorrect recommendation even when it is available. Availability is not consultation.
Workflow design can influence this behavior. Research on cognitive forcing functions found that overreliance decreased when participants formed their own assessment before seeing the AI recommendation. Providing explanations alone did not produce the same effect.
These findings suggest that carefully placed friction may support independent judgment. Treating oversight as a control means defining what the reviewer must assess, how the workflow supports that assessment, what actions are available and what relevant evidence is preserved.
Meaningful oversight requires a reconstructable review context
An organization cannot meaningfully evaluate a review after the fact if it cannot establish what the reviewer was reviewing.
With AI, the model version, configuration and retrieved source material can influence the output presented for review. Reconstructing that review may therefore require knowing which model produced the output, which sources informed it, what information was presented and what the reviewer subsequently changed.
If that context is not preserved when the review occurs, it may be difficult or impossible to reconstruct later. Existing regulations do not necessarily require organizations to capture every element of generative AI provenance, but doing so where relevant can provide stronger evidence that oversight controls operated as intended.
Evidence of oversight extends beyond approval
One approach is to consider two categories of evidence: the conditions under which independent judgment was possible and the actions through which that judgment may be observed.
Conditions can include what information and sources were presented, what authority the reviewer held and what actions the workflow made available. Observable actions can include edits, challenges, disagreements and overrides.
Those actions do not prove meaningful judgment, nor does their absence establish that meaningful review failed to occur. The objective is to preserve evidence appropriate to the oversight function, not to manufacture disagreement or maximize reviewer monitoring.
Taken together, review context, available controls and relevant reviewer actions can provide stronger evidence about how the oversight process operated than an approval and timestamp alone.
A further question is whether the oversight control itself performs as intended. The mammography study offers a useful illustration: researchers introduced known errors and measured whether reviewers identified them. Although conducted as research rather than control qualification, it demonstrates how the effectiveness of human review can be evaluated rather than assumed.
Applying that principle to regulated AI is a proposal, not a current regulatory requirement. It points toward a model in which organizations define the purpose of human oversight, design workflows to support it and evaluate whether the control performs as intended.
That discipline is difficult to sustain when AI-assisted review occurs across an ungoverned collection of general-purpose tools. Designed sequence, presented context, preserved provenance and attributable decisions are easier to establish within a governed workflow than to reconstruct after the fact.
For regulated organizations, the presence of a human reviewer is only the starting point. Meaningful oversight depends on whether the workflow enables independent judgment and preserves enough of the review process to establish how that judgment was exercised. That makes meaningful human oversight, at least in part, a question of workflow design.
How Narrativa can help
Narrativa enables organizations to design governed AI workflows with human oversight built into the process. Reviewers work within defined sequences with access to relevant context and sources, while provenance, review actions and attributable decisions can be preserved as part of the workflow.
This provides a stronger foundation for independent human judgment and a more complete record of how AI-assisted work was reviewed.
About Narrativa
Narrativa® Agentic AI solutions unlock a faster, smarter future for life sciences organizations, helping them to efficiently produce complex, high-volume documentation for regulatory and commercialization workflows. By automating content creation, Narrativa® delivers greater speed, accuracy, and consistency—while ensuring full compliance in highly regulated environments.
The Narrativa® Navigator platform provides secure and specialized Agentic AI-powered automation features. It includes complementary user-friendly tools such as Clinical Atlas for CSR and Protocol generation, Narrative Pathway, TLF Voyager, and Redaction Scout, which operate cohesively to transform clinical data into submission-ready documents for regulatory and commercialization. From database to delivery, pharmaceutical sponsors, biotech firms, and contract research organizations (CROs) rely on Narrativa® to streamline workflows, decrease costs, and reduce time-to-market across the clinical lifecycle and, more broadly, throughout their entire businesses.
Explore www.narrativa.com and follow on LinkedIn, Facebook, Instagram, and X.





